Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A, Weller M, Wen PY, Preusser M (2024) PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a Report of the RANO Group. Lancet Oncol 25:e29–e41. https://doi.org/10.1016/s1470-2045(23)00525-9
Barker FG II, Curry WT Jr, Carter BS (2005) Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neurooncology 7:49–63. https://doi.org/10.1215/S1152851704000146
Baumgarten P, Prange G, Kamp MA, Monden D, Neef V, Schwarzer F, Dubinski D, Dinc N, Weber KJ, Czabanka M, Hattingen E, Ronellenfitsch MW, Steinbach JP, Senft C (2023) Treatment of very elderly glioblastoma patients >/= 75 years of age: whom to treat. J Neurooncol 165:509–515. https://doi.org/10.1007/s11060-023-04518-w
Article PubMed PubMed Central Google Scholar
Berger K, Turowski B, Felsberg J, Malzkorn B, Reifenberger G, Steiger HJ, Budach W, Haussmann J, Knipps J, Rapp M, Hanggi D, Sabel M, Mijderwijk HJ, Kamp MA (2021) Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide. J Cancer Res Clin Oncol 147:253–262. https://doi.org/10.1007/s00432-020-03334-3
Article CAS PubMed Google Scholar
Cairncross G, Wang M, Shaw E, Jenkins R, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, Curran W, Mehta M (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337–343. https://doi.org/10.1200/JCO.2012.43.2674
Article CAS PubMed Google Scholar
De Witt Hamer PC, Ho VKY, Zwinderman AH, Ackermans L, Ardon H, Boomstra S, Bouwknegt W, van den Brink WA, Dirven CM, van der Gaag NA, van der Veer O, Idema AJS, Kloet A, Koopmans J, Ter Laan M, Verstegen MJT, Wagemakers M, Robe P, Quality Registry Neuro Surgery Glioblastoma Working Group from the Dutch Society of Neurosurgery (2019) Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery. J Neurooncol 144:313–323. https://doi.org/10.1007/s11060-019-03229-5
Article PubMed PubMed Central Google Scholar
De Witt Hamer PC, Robles SG, Zwinderman AH, Duffau H, Berger MS (2012) Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol 30:2559–2565. https://doi.org/10.1200/JCO.2011.38.4818
Ferrell B, Chung V, Hughes MT, Koczywas M, Azad NS, Ruel NH, Knight L, Cooper RS, Smith TJ (2021) A palliative care intervention for patients on Phase 1 studies. J Palliat Med 24:846–856. https://doi.org/10.1089/jpm.2020.0597
Article PubMed PubMed Central Google Scholar
Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith TJ (2017) Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35:96–112. https://doi.org/10.1200/JCO.2016.70.1474
Fink L, van Oorschot B, von Sass C, Dibue M, Foster MT, Golla H, Goldbrunner R, Senft C, Lawson McLean A, Hellmich M, Dinc N, Voltz R, Melching H, Jungk C, Kamp MA (2024) Palliative care for in-patient malignant glioma patients in Germany. J Neurooncol 167:323–338. https://doi.org/10.1007/s11060-024-04611-8
Article PubMed PubMed Central Google Scholar
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M (2019) Lomustine–temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. Lancet 393:678–688. https://doi.org/10.1016/s0140-6736(18)31791-4
Article CAS PubMed Google Scholar
Karschnia P, Dono A, Young JS, Juenger ST, Teske N, Häni L, Sciortino T, Mau CY, Bruno F, Nunez L, Morshed RA, Haddad AF, Weller M, van den Bent M, Thon N, Beck J, Hervey-Jumper S, Molinaro AM, Tandon N, Rudà R, Vogelbaum MA, Bello L, Schnell O, Grau SJ, Chang SM, Berger MS, Esquenazi Y, Tonn J-C (2024) Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: a complementary report of the RANO Resect Group. Neuro-oncology 26:584–586. https://doi.org/10.1093/neuonc/noad237
Lassen B, Helseth E, Ronning P, Scheie D, Johannesen TB, Maehlen J, Langmoen IA, Meling TR (2011) Surgical mortality at 30 days and complications leading to recraniotomy in 2630 consecutive craniotomies for intracranial tumors. Neurosurgery 68:1259–1268; discussion 1268–1259. https://doi.org/10.1227/NEU.0b013e31820c0441
Lofgren D, Valachis A, Olivecrona M (2022) Risk for morbidity and mortality after neurosurgery in older patients with high grade gliomas—a retrospective population based study. BMC Geriatr 22:805. https://doi.org/10.1186/s12877-022-03478-6
Article PubMed PubMed Central Google Scholar
Long DM, Gordon T, Bowman H, Etzel A, Burleyson G, Betchen S, Garonzik IM, Brem H (2003) Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers. Neurosurgery 52:1056–1065. https://doi.org/10.1227/01.Neu.0000057745.48813.93
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro-oncology 23:1231–1251. https://doi.org/10.1093/neuonc/noab106
Article CAS PubMed PubMed Central Google Scholar
Malmström A, Grønberg BH, Marosi C, Stupp R, Frappaz D, Schultz H, Abacioglu U, Tavelin B, Lhermitte B, Hegi ME, Rosell J, Henriksson R (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, Phase 3 trial. Lancet Oncol 13:916–926. https://doi.org/10.1016/s1470-2045(12)70265-6
Mijderwijk HJ, Nieboer D, Incekara F, Berger K, Steyerberg EW, van den Bent MJ, Reifenberger G, Hanggi D, Smits M, Senft C, Rapp M, Sabel M, Voss M, Forster MT, Kamp MA (2022) Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastoma. J Neurosurg. https://doi.org/10.3171/2021.10.JNS211261
Ostrom QT, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2021) CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neuro-oncology 23:iii1–iii105. https://doi.org/10.1093/neuonc/noab200
Article PubMed PubMed Central Google Scholar
Pace A, Dirven L, Koekkoek JAF, Golla H, Fleming J, Ruda R, Marosi C, Le Rhun E, Grant R, Oliver K, Oberg I, Bulbeck HJ, Rooney AG, Henriksson R, Pasman HRW, Oberndorfer S, Weller M, Taphoorn MJB, European Association of Neuro-Oncology Palliative Care Task Force (2017) European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol 18:e330–e340. https://doi.org/10.1016/S1470-2045(17)30345-5
Perry JR, Laperriere N, O’Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, Osoba D, Rossiter JP, Sahgal A, Hirte H, Laigle-Donadey F, Franceschi E, Chinot O, Golfinopoulos V, Fariselli L, Wick A, Feuvret L, Back M, Tills M, Winch C, Baumert BG, Wick W, Ding K, Mason WP, Trial Investigators (2017) Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med 376:1027–1037. https://doi.org/10.1056/NEJMoa1611977
Article CAS PubMed Google Scholar
Poppe JP, Machegger L, Steinbacher J, Stefanits H, Eisschiel S, Gruber A, Demetz M, Ladisich B, Kraus TFJ, Weis S, Spiegl-Kreinecker S, Romagna A, Griessenauer CJ, Jahromi BR, Rautalin I, Niemela M, Korja M, Schwartz C (2023) Surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study. J Neurooncol 161:563–572. https://doi.org/10.1007/s11060-023-04252-3
Article PubMed PubMed Central Google Scholar
Saunders C (1975) The care of the dying patient and his family. Doc Med Ethics. https://doi.org/10.1080/13520806.1972.11759235
Schwarzkopf D, Rose N, Fleischmann-Struzek C, Boden B, Dorow H, Edel A, Friedrich M, Gonnert FA, Gotz J, Grundling M, Heim M, Holbeck K, Jaschinski U, Koch C, Kunzer C, Le Ngoc K, Lindau S, Mehlmann NB, Meschede J, Meybohm P, Ouart D, Putensen C, Sander M, Schewe JC, Schlattmann P, Schmidt G, Schneider G, Spies C, Steinsberger F, Zacharowski K, Zinn S, Reinhart K (2023) Understanding the biases to sepsis surveillance and quality assurance caused by inaccurate coding in administrative health data. Infection. https://doi.org/10.1007/s15010-023-02091-y
Article PubMed PubMed Central Google Scholar
Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V (2011) Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12:997–1003. https://doi.org/10.1016/s1470-2045(11)70196-6
Stummer W, Kamp MA (2009) The importance of surgical resection in malignant glioma. Curr Opin Neurol 22:645–649. https://doi.org/10.1097/WCO.0b013e3283320165
Comments (0)